eLearning modules

These CPD modules have been developed in partnership with pharmaceutical companies and may contain pharmaceutical promotional information. Please also see: Guidelines Learning

eLearning module_Deep dive on SGLT2 inhibitors_index image

Deep dive on SGLT2 inhibitors with a focus on Jardiance® (empagliflozin)

Promotional material from the Boehringer Ingelheim and Lilly Diabetes Alliance

This eLearning module has been commissioned and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice and Guidelines Learning. Products are discussed.
View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
PC-GB-104397 April 2021

Deep dive on DPP-4 inhibitors

Deep dive on DPP-4 inhibitors with a focus on Trajenta® (linagliptin)

Promotional material from Boehringer Ingelheim Limited

This eLearning module and the associated videos have been commissioned and funded by Boehringer Ingelheim. The module and associated videos contain promotional content. For UK healthcare professionals.
View Trajenta® (linagliptin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain or Northern Ireland
PC-GB-104526 July 2021